IP Library Assignment 025198/0735
Patent Assignment
Reel/Frame 025198/0735

Assignment of Assignor's Interest

Recorded: 2010-10-26 Pages: 41
Assignor
CONJUCHEM BIOTECHNOLOGIES INC.
Executed: 2010-08-23
Assignee
ADVANCED DIAGNOSTICS AND DISCOVERY
149 SOUTH BARRINGTON - #311, LOS ANGELES, CALIFORNIA, 90049
Covered Properties (49)
Super-Globulins for in Vivo Extended Lifetimes
Patent: 5,612,034 →
Application: 08/237,346 →
Cellular and Serum Protein Anchors and Conjugates
Patent: 6,103,233 →
Application: 08/477,900 →
Affinity Labeling Libraries and Applications Thereof
Patent: 6,277,583 →
Application: 08/598,054 →
Cellular and Serum Protein Anchors for Modulating Pharmacokinetics.
Patent: 5,843,440 →
Application: 08/702,127 →
Affinity Labeling Libraries with Tagged Leaving Group
Patent: 6,403,324 →
Application: 09/042,234 →
Extended Lifetimes in Vivo Renin Inhibitors
Patent: 6,107,489 →
Application: 09/267,274 →
Methods of Treating or Preventing Thromboses
Patent: 6,087,375 →
Application: 09/330,744 →
Novel Conjugates of Opioids and Endogenous Carriers
Patent: 6,437,092 →
Application: 09/445,986 →
Long-Lasting Antiviral Fusion Inhibitor Peptide Conjugates Comprising Albumin and Human Immunodeficiency Virus (Hiv) Peptides.
Patent: 7,582,301 →
Application: 09/623,533 →
Protection of Endogenous Therapeutic Peptides from Peptidase Activity Through Conjugation to Blood Components
Patent: 6,849,714 →
Application: 09/623,548 →
Long lasting insulinotropic peptides
Patent: 6,329,336 →
Application: 09/623,618 →
Pulmonary Delivery for Bioconjugation
Patent: 6,706,892 →
Application: 09/656,121 →
Protection of Endogenous Therapeutic Peptides from Peptidase Activity Through Conjugation to Blood Components
Patent: 6,887,470 →
Application: 09/657,276 →
Long Lasting Synthetic Glucagon Like Peptide {Glp-!}
Patent: 6,514,500 →
Application: 09/657,332 →
Long Lasting Fusion Peptide Inhibitors of Viral Infection
Patent: 7,090,851 →
Application: 09/657,336 →
Long Lasting Anti--Angiogenic Peptides
Patent: 7,144,854 →
Application: 09/657,431 →
Antinociceptive Agent Derivative
Patent: 6,602,981 →
Application: 09/798,114 →
Publication: US 2002/0039999
Method for Alleviating Pain or Providing an Analgesic Effect in a Patient
Patent: 6,610,825 →
Application: 09/798,119 →
Publication: US 2001/0018420
Long Lasting Insulinotropic Peptides
Patent: 6,593,295 →
Application: 09/876,388 →
Publication: US 2002/0049153
Long Lasting Glucagon-Like PEPTIDE2(Glp-2)for the Treatment of Gastrointestinal Diseases and Disorders
Patent: 7,112,567 →
Application: 10/203,808 →
Publication: US 2004/0248782
Long Lasting Growth Hormone Releasing Factor Derivatives
Patent: 7,268,113 →
Application: 10/203,809 →
Publication: US 2003/0073630
Long Lasting Synthetic Glucagon-Like Peptide {Glp-1}
Patent: 6,821,949 →
Application: 10/287,892 →
Publication: US 2003/0108567
Long Lasting Synthetic Glucagon-Like Peptide {Glp-1}
Patent: 6,887,849 →
Application: 10/288,340 →
Publication: US 2003/0108568
Long Lasting Fusion Peptide Inhibitors for Hiv Infection
Patent: 7,741,453 →
Application: 10/478,811 →
Publication: US 2005/0065075
Long lasting insulin derivatives and methods thereof
Application: 10/565,900 →
Publication: US 2006/0241019
Affinity Markers for Human Serum Albumin
Patent: 7,166,695 →
Application: 10/934,841 →
Publication: US 2005/0037974
Modified Human Immunodeficiency Virus Anti-Fusogenic GP41 Peptides Comprising a Maleimide-Containing Group.
Patent: 7,608,271 →
Application: 10/950,010 →
Publication: US 2005/0070475
Protection of Endogenous Therapeutic Peptides from Peptidase Activity Through Conjugation to Blood Components
Patent: 7,256,253 →
Application: 11/066,697 →
Publication: US 2005/0187159
Anti-Obesity Agents
Patent: 7,601,691 →
Application: 11/067,556 →
Publication: US 2005/0176643
Method for Purification of Albumin Conjugates
Patent: 7,307,148 →
Application: 11/112,277 →
Publication: US 2005/0267293
Long Lasting Synthetic Exendin-4 Peptide Conjugates
Patent: 8,080,516 →
Application: 11/170,967 →
Publication: US 2006/0009377
Methods Involving Long Lasting Synthetic Exendin-4-Peptide Conjugates
Patent: 8,084,414 →
Application: 11/215,967 →
Publication: US 2006/0058235
Methods Involving Long Lasting Synthetic Exendin-4 Peptide Conjugates
Patent: 8,093,206 →
Application: 11/304,446 →
Publication: US 2006/0135426
Long Lasting Glucagon-Like Peptide 2 (Glp-2) for the Treatment of Gastrointestinal Diseases and Disorders
Patent: 7,737,251 →
Application: 11/318,323 →
Publication: US 2006/0217304
Long Lasting Anti-Angiogenic Peptides
Patent: 7,741,286 →
Application: 11/350,703 →
Publication: US 2006/0135428
Compounds For Specific Viral Target
Application: 11/579,929 →
Publication: US 2008/0039532
Method of Treatment of Diabetes and/or Obesity with Reduced Nausea Side Effect
Patent: 8,039,432 →
Application: 11/595,576 →
Publication: US 2007/0207958
Process for the production of preformed conjugates of albumin and a therapeutic agent
Application: 11/645,297 →
Publication: US 2007/0269863
Modified Corticotropin Releasing Factor Peptides and Uses Thereof
Patent: 7,982,018 →
Application: 11/873,291 →
Publication: US 2008/0167231
Long Lasting Fusion Peptide Inhibitors of Viral Infection
Application: 11/877,221 →
Publication: US 2008/0199483
Long Lasting Fusion Peptide Inhibitors of Viral Infection
Application: 11/877,300 →
Publication: US 2008/0176794
Novel Anti-Obesity Agents
Patent: 7,906,482 →
Application: 11/923,222 →
Publication: US 2008/0194486
Modulating Food Intake
Application: 11/965,288 →
Publication: US 2009/0099074
Method for the purification of albumin conjugates
Application: 11/981,474 →
Publication: US 2008/0146783
Modified therapeutic peptides with extended half-lives in vivo
Application: 11/982,033 →
Publication: US 2009/0175821
Cysteic Acid Derivatives of Anti-Viral Peptides
Application: 12/122,627 →
Publication: US 2009/0088377
Long lasting synthetic exendin-4 peptide conjugates and methods of use thereof
Application: 12/221,553 →
Publication: US 2009/0075890
Protection of exendin-4 peptides through conjugation
Application: 12/221,554 →
Publication: US 2009/0093408
Long Lasting Natriuretic Peptide Derivatives
Application: 12/253,856 →
Publication: US 2009/0275506
Related Assignments (25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Jul 18, 1994
From: POULETTY, CHRISTINE
To: REDCELL, INC.
Reel/Frame 007062/0144 →
Assignment of Assignor's Interest Apr 8, 1996
From: KRANTZ, ALEXANDER, PH.D.; HANEL, ARTHUR M., PH.D.; HUANG, WOLIN, PH.D.
To: REDCELL, INC.
Reel/Frame 007953/0644 →
Assignment of Assignor's Interest May 20, 1997
From: REDCELL, INC.
To: REDCELL CANADA, INC.
Reel/Frame 008512/0993 →
Assignment of Assignor's Interest Aug 11, 1997
From: POULETTY, CHRISTINE; POULETTY, PHILIPPE
To: REDCELL, INC.
Reel/Frame 008649/0335 →
Assignment of Assignor's Interest Jun 1, 1998
From: KRANTZ, ALEXANDER; HANEL, ARTHUR M.
To: REDCELL CANADA, INC.
Reel/Frame 009230/0429 →
Change of Name Jul 1, 1998
From: CONJUCHEM, INC.
To: CONJUCHEM, INC.
Reel/Frame 009299/0663 →
Change of Name Jul 6, 1998
From: CONJUCHEM, INC.
To: CONJUCHEM, INC.
Reel/Frame 009314/0891 →
Assignment of Assignor's Interest Sep 3, 1998
From: HUANG, WOLIN
To: CONJUCHEM, INC.
Reel/Frame 009442/0422 →
Assignment of Assignor's Interest Jan 14, 1999
From: REDCELL CANADA, INC.
To: CONJUCHEM, INC.
Reel/Frame 009691/0878 →
Change of Name Jan 14, 1999
From: REDCELL CANADA. INC.
To: CONJUCHEM, INC.
Reel/Frame 009691/0866 →
Change of Name Jan 14, 1999
From: REDCELL CANADA, INC.
To: CONJUCHEM, INC.
Reel/Frame 009689/0838 →
Change of Name Jan 14, 1999
From: REDCELL CANADA, INC.
To: CONJUCHEM, INC.
Reel/Frame 009689/0830 →
Change of Name Jan 14, 1999
From: REDCELL CANADA, INC.
To: CONJUCHEM, INC.
Reel/Frame 009694/0559 →
Assignment of Assignor's Interest Aug 16, 1999
From: BRIDON, DOMINIQUE P.; EZRIN, ALAN; MILNER, PETER
To: CONJUCHEM, INC.
Reel/Frame 010170/0493 →
Assignment of Assignor's Interest Sep 7, 1999
From: KRANTZ, ALEXANDER; SONG, YONGHONG; BLANCHARD, DOMINIQUE; DENAGEL, DIANE
To: CONJUCHEM, INC.
Reel/Frame 010214/0425 →
Assignment of Assignor's Interest Dec 16, 1999
From: EZRIN, ALAN M.; BRIDON, DOMINIQUE P.; HOLMES, DARREN L.; MILNER, PETER G.
To: CONJUCHEM, INC.
Reel/Frame 010577/0491 →
Assignment of Assignor's Interest Sep 5, 2000
From: BRIDON, DOMINIQUE; EZRIN, ALAN M.; MILNER, PETER G.; HOLMES, DARREN L.
To: CONJUCHEM, INC.
Reel/Frame 011166/0054 →
Assignment of Assignor's Interest Sep 5, 2000
From: BRIDON, DOMINIQUE P.; DUFRESNE, ROBERT S.; BOUDJELLAB, NISSAB; ROBITAILLE, MARTIN
To: CONJUCHEM, INC.
Reel/Frame 011186/0640 →
Assignment of Assignor's Interest Sep 6, 2000
From: EZRIN, ALAN M.; FLESER, ANGELICA; ROBITAILLE, MARTIN; MILNER, PETER G.
To: CONJUCHEM, INC.
Reel/Frame 011150/0690 →
Assignment of Assignor's Interest Sep 7, 2000
From: BRIDON, DOMINIQUE P.; L'ARCHEVEQUE, BENOIT; EZRIN, ALAN M.; HOLMES, DARREN L.
To: CONJUCHEM, INC.
Reel/Frame 011070/0471 →
Assignment of Assignor's Interest Sep 7, 2000
From: BRIDON, DOMINIQUE; RASAMOELISOLO, MICHELE; THIBAUDEAU, KAREN; HUANG, XICAI
To: CONJUCHEM, INC.
Reel/Frame 011068/0782 →
Assignment of Assignor's Interest Sep 7, 2000
From: BRIDON, DOMINIQUE P.; DUFRESNE, ROBERT S.; BOUDJELLAB, NISSAB; ROBITAILLE, MARTIN
To: CONJUCHEN, INC.
Reel/Frame 011081/0868 →
Assignment of Assignor's Interest Sep 7, 2000
From: BRIDON, DOMINIQUE P.; EZRIN, ALAN M.; MILNER, PETER G.; HOLMES, DARREN L.
To: CONJUCHEM, INC.
Reel/Frame 011083/0096 →
Assignment of Assignor's Interest Oct 2, 2000
From: BRIDON, DOMINIQUE P.; L'ARCHEVEQUE, BENOIT; EZRIN, ALAN M.; HOLMES, DARREN L.
To: CONJUCHEM, INC.
Reel/Frame 011143/0515 →
Assignment of Assignor's Interest Oct 2, 2000
From: BRIDON, DOMINIQUE P.; L'ARCHEVEQUE, BENOIT; EZRIN, ALAN M.; HOLMES, DARREN L.
To: CONJUCHEM, INC.
Reel/Frame 011222/0519 →